FDA alerts health care providers that the use of passive protective barrier enclosures when treating Covid-19 patients may pose an increased health ri...
FDA cites Living Senior, Las Vegas, NV, over its www.blueribbonhemp.com Web site that markets CBD products for treating Covid-19 patients.
Federal Register notice: FDA announces a 10/7 meeting of its Medical Devices Advisory Committees Circulatory System Devices Panel, which will discuss ...
Bayshore Pharmaceuticals recall two lots of metformin hydrochloride extended-release tablets due to the detection of N-nitrosodimethylamine levels abo...
Federal Register notice: FDA sends to OMB an information collection extension on Focus Groups as Used by the Food and Drug Administration (All FDA-Reg...
Federal Register notice: FDA seeks comments on a revised information collection on Registration of Human Drug Compounding Outsourcing Facilities and A...
Federal Register notice: FDA sends to OMB an information collection on medical device corrections and removals reporting.
A new Trump Administration initiative exempts laboratory-developed tests, including those for Covid-19, from the need to get FDA premarket review.